PT - JOURNAL ARTICLE AU - Lammer, Laurenz AU - Beyer, Frauke AU - Luppa, Melanie AU - Sander, Christian AU - Baber, Ronny AU - Engel, Christoph AU - Wirkner, Kerstin AU - Loeffler, Markus AU - Riedel-Heller, Steffi G AU - Villringer, Arno AU - Witte, Veronica TI - Social isolation is linked to declining grey matter structure and cognitive functions in the LIFE-Adult panel study AID - 10.1101/2021.12.14.21267787 DP - 2022 Jan 01 TA - medRxiv PG - 2021.12.14.21267787 4099 - http://medrxiv.org/content/early/2022/09/23/2021.12.14.21267787.short 4100 - http://medrxiv.org/content/early/2022/09/23/2021.12.14.21267787.full AB - Social isolation has been suggested to increase the risk to develop cognitive decline. However, our knowledge on causality and neurobiological underpinnings is still limited. In this preregistered analysis, we tested the impact of social isolation on central features of brain and cognitive aging using a longitudinal population-based magnetic resonance imaging (MRI) study. Assaying 1335 cognitively healthy participants (50-80 years old, 659 women) at baseline and 895 participants after ∼6 years follow-up, we found baseline social isolation and change in social isolation to be associated with smaller volumes of the hippocampus, reduced cortical thickness and poorer cognitive functions. Combining advanced neuroimaging outcomes with prevalent lifestyle characteristics from a well-characterized population of middle- to older aged adults, we provide evidence that social isolation contributes to human brain atrophy and cognitive decline. Within-subject effects of social isolation were similar to between-subject effects, indicating an opportunity to reduce dementia risk by promoting social networks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants of the European Union, the European Regional Development Fund, the Free State of Saxony within the framework of the excellence initiative, the LIFE–Leipzig Research Center for Civilization Diseases, University of Leipzig [project numbers: 713–241202, 14505/2470, 14575/2470] and by grants of the German Research Foundation, contract grant numbers 209933838 CRC1052–03 A1 (VW) and WI 3342/3–1 (VW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional ethics board of the Medical Faculty of the University of Leipzig.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to LIFE - Leipziger Forschungszentrum für Zivilisationserkrankungen (https://www.life.uni-leipzig.de/en/life_health_study.html).